ArticleBJR artificial intelligence2026
Independent validation of the Mosamatic deep learning automated skeletal muscle and adipose tissue segmentation tool in an external Chinese cancer patient cohort.
Article in BJR artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Deep learning neural network (DLNN)-based tools can automate body composition analysis for cancer cachexia research. We aimed to evaluate a DLNN tool trained on a European population of Chinese cancer patients. Methods: Computed tomography (CT) images at the 3rd lumbar vertebral (L3) level of Chinese gastric cancer patients were retrospectively collected. An externally validated DLNN tool (Mosamatic) was used to segment skeletal muscle, visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT). Manual segmentation was performed using SliceOmatic software (TomoVision, version 5.0). Geometric similarity between automated and manual segmentation, and the reliability was assessed. Results: The cohort comprised 203 patients with a median body mass index (BMI) of 22.2 kg/m Conclusions: The Mosamatic tool displays excellent generalizability to analyse body compositions in Chinese gastric cancer patients and can facilitate cachexia research. Advances in knowledge: The Mosamatic tool displayed excellent generalizability without recalibration to analyse body composition on the 3rd lumbar vertebral CT images in Chinese gastric cancer patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.